Medtronic Other Segment — Net Sales remained flat by 0.0% to $34.25M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 38.0%, from $55.25M to $34.25M. Over 2 years (FY 2023 to FY 2025), Other Segment — Net Sales shows a downward trend with a -47.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests growth in non-core business areas or the successful incubation of new product lines, while a decrease may indicate divestitures or the winding down of legacy operations.
This metric represents the total revenue generated by business activities that do not fall into the company's primary re...
Peers often report this as 'Other' or 'Corporate and Other' revenue, which typically represents a small fraction of total consolidated sales.
mdt_segment_other_segment_net_sales| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $495.00M | $221.00M | $137.00M |
| YoY Change | — | -55.4% | -38.0% |